Why Hers Is Betting Big on Menopause: Breaking Into Women's Health's Biggest Untapped Market

The digital health platform Hers just made a major move: launching a dedicated menopause and perimenopause specialty with one clear goal in mind—reaching its $1 billion revenue target by 2026. But this isn’t just another product launch. It’s a calculated entry into one of healthcare’s most overlooked segments.

The Market Gap Nobody’s Filling

Here’s the problem: Around 1.3 million American women enter menopause every year, yet only 30% of OB/GYN training programs formally teach menopause care. Women are left navigating symptoms—hot flashes, sleep disruption, mood changes—largely on their own, without professional guidance.

That’s where Hers sees its opening. The platform already serves over 500,000 subscribers and has built a reputation for removing friction from healthcare access. Now it’s applying that same model to women’s health at a critical life stage.

What Hers Is Actually Offering

The new menopause specialty isn’t just about prescriptions. Each woman gets matched with a licensed provider trained specifically in perimenopause and menopause care, who designs personalized treatment plans. Eligible patients can access medications including estradiol (to manage hot flashes and night sweats) and progesterone (for sleep and uterine support), available in multiple forms—pills, patches, or creams.

The kicker: providers can adjust treatment plans over time based on individual response. Hers also plans to expand its treatment options next year, suggesting this is just the first wave.

Why This Timing Matters

Women spend an average of nine years dealing with poor health—25% longer than men—which directly impacts work performance and personal life. Hers recognizes this as both a healthcare crisis and a massive business opportunity. By building a specialty around menopause care, the company can deepen its relationship with existing subscribers while acquiring new ones who specifically need this service.

The expansion signals Hers’ confidence in its path toward $1 billion in annual revenue by end of 2026. Each new specialty strengthens the platform’s position as a comprehensive women’s health destination, not just a general telehealth service.